重症患者按年龄分层的死亡率:CIMbA-LT长期随访研究
CIMbA-LT是一项多中心、全国性、回顾性、观察性研究,纳入葡萄牙综合ICU收治的37118例患者,其中15.8%超过80岁,平均SAPS II评分42.8±19.4,随访至入ICU后两年。ICU全因死亡率为16.1%,76%患者存活至出院;SAPS II高估医院死亡率(出院时SMR 0.7,95%CI 0.63-0.76),但准确预测一年全因死亡率(1年SMR 1.01,95%CI 0.98-1.08)。生存曲线显示死亡高峰在最初30天,之后生存下降明显放缓;高龄患者短期和长期死亡率更高,医院SMR也略高(0.76 vs 0.69)。存活出院患者一年相对死亡风险为6.3(95%CI 5.8-6.7),年轻患者更高(21.1,95%CI 15.1-39.6 vs 2.4,95%CI 2.2-2.7)。
要点
- 37,118例ICU患者中15.8%超过80岁,ICU全因死亡率16.1%,76%存活至出院。
- SAPS II高估医院死亡率(出院时SMR 0.7,95%CI 0.63-0.76),但准确预测一年全因死亡率(1年SMR 1.01,95%CI 0.98-1.08)。
- 生存曲线显示死亡高峰在入ICU后最初30天,之后生存下降明显放缓。
- 高龄患者短期和长期死亡率更高,医院SMR也略高(0.76 vs 0.69)。
- 存活出院患者一年相对死亡风险为6.3(95%CI 5.8-6.7),年轻患者更高(21.1,95%CI 15.1-39.6 vs 2.4,95%CI 2.2-2.7)。
适用人群与场景
- 葡萄牙综合ICU收治的危重患者,纳入37,118例,其中15.8%超过80岁,平均SAPS II评分42.8±19.4。
- 随访至入ICU后两年。
研究设计与关键结果
- CIMbA-LT为多中心、全国性、回顾性、观察性研究,纳入葡萄牙综合ICU在4年内收治的37,118例患者,按年龄和疾病严重程度分析短期和长期预后,随访至入ICU后两年。
- ICU全因死亡率为16.1%,76%患者存活至出院。
- SAPS II高估医院死亡率(出院时SMR 0.7,95%CI 0.63-0.76),但准确预测一年全因死亡率(1年SMR 1.01,95%CI 0.98-1.08)。
- 生存曲线显示死亡高峰在最初30天,之后生存下降明显放缓。
- 高龄患者短期和长期死亡率更高,医院SMR也略高(0.76 vs 0.69)。
- 存活出院患者一年相对死亡风险为6.3(95%CI 5.8-6.7),年轻患者更高(21.1,95%CI 15.1-39.6 vs 2.4,95%CI 2.2-2.7)。
证据类型、等级与局限
- 证据类型:多中心、全国性、回顾性、观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,ICU死亡高峰在入ICU后30天内,高龄患者短期和长期死亡率及医院SMR更高,存活出院者长期相对死亡风险升高且年轻患者更明显。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The past years have witnessed dramatic changes in the population admitted to the intensive care unit (ICU). Older and sicker patients are now commonly treated in this setting due to the newly available sophisticated life support. However, the short- and long-term benefit of this strategy is scarcely studied.
METHODS: The Critically Ill patients' mortality by age: Long-Term follow-up (CIMbA-LT) was a multicentric, nationwide, retrospective, observational study addressing short- and long-term prognosis of patients admitted to Portuguese multipurpose ICUs, during 4 years, according to their age and disease severity. Patients were followed for two years after ICU admission. The standardized hospital mortality ratio (SMR) was calculated according to the Simplified Acute Physiology Score (SAPS) II and the follow-up risk, for patients discharged alive from the hospital, according to official demographic national data for age and gender. Survival curves were plotted according to age group.
RESULTS: We included 37.118 patients, including 15.8% over 80 years old. The mean SAPS II score was 42.8 ± 19.4. The ICU all-cause mortality was 16.1% and 76% of all patients survive until hospital discharge. The SAPS II score overestimated hospital mortality [SMR at hospital discharge 0.7; 95% confidence interval (CI) 0.63-0.76] but accurately predicted one-year all-cause mortality [1-year SMR 1.01; (95% CI 0.98-1.08)]. Survival curves showed a peak in mortality, during the first 30 days, followed by a much slower survival decline thereafter. Older patients had higher short- and long-term mortality and their hospital SMR was also slightly higher (0.76 vs. 0.69). Patients discharged alive from the hospital had a 1-year relative mortality risk of 6.3; [95% CI 5.8-6.7]. This increased risk was higher for younger patients [21.1; (95% CI 15.1-39.6) vs. 2.4; (95% CI 2.2-2.7) for older patients].
CONCLUSIONS: Critically ill patients' mortality peaked in the first 30 days after ICU admission. Older critically ill patients had higher all-cause mortality, including a higher hospital SMR. A long-term increased relative mortality risk was noted in patients discharged alive from the hospital, but this was more noticeable in younger patients.
参考来源
- Gonçalves-Pereira J, Oliveira A, Vieira T, et al. Critically ill patient mortality by age: long-term follow-up (CIMbA-LT). Ann Intensive Care. 2023. PMID: 36764980. doi:10.1186/s13613-023-01102-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。